RecruitingNot ApplicableNCT06945120

ACT Lung Health Intervention: Phase Two

Efficacy of an Asian Culture-tailored Lung Health (ACT) Intervention on Lung Cancer Screening and Smoking Cessation in Asian Americans

Sponsor

Dana-Farber Cancer Institute

Enrollment

50 participants

Start Date

Nov 4, 2025

Study Type

INTERVENTIONAL

Conditions

Smoking Cessation Smoking Behaviors Smoking, Tobacco Smoking, Cigarette Smoking (Tobacco) Addiction

Summary

This study aims to test a counseling and educational program designed to improve lung health through smoking cessation for Chinese and Korean American smokers at high risk for lung cancer.

Eligibility

Min Age: 18 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a culturally tailored program to help Chinese and Korean immigrants in the US quit smoking. The intervention is designed to be delivered in their native languages and is sensitive to their cultural backgrounds. **You may be eligible if...** - You identify as Chinese or Korean - You speak Mandarin, Korean, or English - You are 18 years old or older - You currently smoke cigarettes (have smoked at least 100 cigarettes in your life and smoked at least one in the past 30 days) - You plan to remain living in the United States for the next 12 months **You may NOT be eligible if...** - You were hospitalized for a serious mental illness (such as psychosis) in the past 6 months - You are unable to provide informed consent - You are under 18 years old Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALACT Lung Health Intervention

An Asian culture-tailored lung health intervention, which includes individual counseling sessions, family coaching, provision of nicotine replacement therapy (NRT) in the form of patches, lozenges, or chewing gum, and educational materials about low-dose computed tomography (LDCT) for lung cancer screening. The eight weekly, counseling sessions with study staff will be conducted via phone call or the Zoom web-conferencing platform.

Locations(2)

Dana-Farber Cancer Institute

Boston, Massachusetts, United States

University of Massachusetts-Boston

Boston, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06945120

Related Trials

Evaluation of a Novel mHealth Intervention for People Who Are Ambivalent About Quitting Smoking

NCT074596211 location

Metabolism-Informed Care to Aid Alaska Native People to Quit Smoking (QUIT)

NCT065562381 location